Trial Profile
Efficacy of combined androgen blockade with zoledronic acid treatment in prostate cancer with bone metastasis: The Zoledronic Acid/Androgen Blockade Trial on Prostate Cancer (Zabton-PC) study.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Mar 2014
Price :
$35
*
At a glance
- Drugs Zoledronic acid (Primary) ; Antiandrogens
- Indications Prostate cancer
- Focus Therapeutic Use
- Acronyms ZABTON-PC
- 20 Mar 2014 New trial record
- 01 Feb 2014 Results presented at the 2014 Genitourinary Cancers Symposium.